miralax
Generic: polyethylene glycol 3350
Labeler: cardinal health 107, llcDrug Facts
Product Profile
Brand Name
miralax
Generic Name
polyethylene glycol 3350
Labeler
cardinal health 107, llc
Dosage Form
POWDER, FOR SOLUTION
Routes
Active Ingredients
polyethylene glycol 3350 17 g/17g
Manufacturer
Identifiers & Regulatory
Product NDC
55154-5035
Product ID
55154-5035_a30d3776-09c8-41aa-9282-ba2486632e07
Product Type
HUMAN OTC DRUG
Marketing Category
NDA
Application Number
NDA022015
Listing Expiration
2026-12-31
Marketing Start
2009-02-23
Pharmacologic Class
Established (EPC)
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
551545035
Hyphenated Format
55154-5035
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
miralax (source: ndc)
Generic Name
polyethylene glycol 3350 (source: ndc)
Application Number
NDA022015 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 17 g/17g
Packaging
- 6 PACKET in 1 BAG (55154-5035-6) / 17 g in 1 PACKET
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "a30d3776-09c8-41aa-9282-ba2486632e07", "openfda": {"nui": ["N0000010288", "N0000175811", "N0000009871"], "upc": ["0055154503563"], "unii": ["G2M7P15E5P"], "rxcui": ["876193", "876195"], "spl_set_id": ["1771d3bf-954d-49ea-b260-3d356e5dcfa5"], "pharm_class_pe": ["Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "pharm_class_epc": ["Osmotic Laxative [EPC]"], "pharm_class_moa": ["Osmotic Activity [MoA]"], "manufacturer_name": ["Cardinal Health 107, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "6 PACKET in 1 BAG (55154-5035-6) / 17 g in 1 PACKET", "package_ndc": "55154-5035-6", "marketing_start_date": "20090223"}], "brand_name": "MiraLAX", "product_id": "55154-5035_a30d3776-09c8-41aa-9282-ba2486632e07", "dosage_form": "POWDER, FOR SOLUTION", "pharm_class": ["Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "product_ndc": "55154-5035", "generic_name": "Polyethylene Glycol 3350", "labeler_name": "Cardinal Health 107, LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "MiraLAX", "active_ingredients": [{"name": "POLYETHYLENE GLYCOL 3350", "strength": "17 g/17g"}], "application_number": "NDA022015", "marketing_category": "NDA", "marketing_start_date": "20090223", "listing_expiration_date": "20261231"}